The Former Attorney General of Louisiana & Kahn Swick & Foti, LLC Remind Large Investors of Lead Plaintiff Deadline in Class Action Lawsuit Against PTC Therapeutics, Inc. - PTCT

NEW ORLEANS, LA--(Marketwired - March 18, 2016) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until May 2, 2016 to file lead plaintiff applications in a securities class action lawsuit against PTC Therapeutics, Inc. (PTCT), if they purchased the Company's securities between the expanded period of May 6, 2014 and February 29, 2016, inclusive (the "Class Period"). This action is pending in the United States District Court for the District of New Jersey.

What You May Do

If you purchased shares of PTC and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn (lewis.kahn@ksfcounsel.com). If you wish to serve as a lead plaintiff in this class action, you must petition the Court by May 2, 2016.

About the Lawsuit

PTC and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.

On February 23, 2016, PTC disclosed that it has received a Refuse to File letter from the United States Food and Drug Administration (FDA) regarding PTC's New Drug Application (NDA) for Translarna for the treatment of muscular dystrophy. PTC further disclosed that the FDA's Refuse to File letter stated "that the application was not sufficiently complete to permit a substantive review."

On this news, the price of PTC's shares plummeted by over 61%.

About Kahn Swick & Foti, LLC

KSF, whose partners include the Former Louisiana Attorney General Charles C. Foti, Jr., is a law firm focused on securities, antitrust and consumer class actions, along with merger & acquisition and breach of fiduciary litigation against publicly traded companies on behalf of shareholders. The firm has offices in New York, California and Louisiana.

To learn more about KSF, you may visit www.ksfcounsel.com.